Atherectomy Devices Market Poised for 8% CAGR Growth Through 2032

The Atherectomy Devices Market, valued at USD 1.2 billion in 2022, is projected to reach USD 2.5 billion by 2032, registering a CAGR of 8% from 2023 to 2032. This growth can be attributed to several factors. The increasing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, significantly drives market expansion. Additionally, the rising preference for minimally invasive procedures, which offer reduced recovery times and lower complication risks, contributes to the growing adoption of atherectomy devices.

Technological advancements in atherectomy devices, such as the development of laser atherectomy and rotational atherectomy systems, are enhancing treatment efficacy and safety, further propelling market growth. However, the market faces challenges, including high costs associated with atherectomy procedures and devices, which can be a barrier for widespread adoption. Furthermore, stringent regulatory requirements and a shortage of skilled healthcare professionals also pose challenges to market growth.

Recent developments in the market include significant acquisitions and product launches aimed at expanding product portfolios and enhancing technological capabilities. For instance, Abbott’s acquisition of Cardiovascular Systems, Inc. in 2023 for approximately USD 890 million is expected to bolster its position in the vascular treatment market. Similarly, the approval of AngioDynamics’ Auryon Atherectomy System by the FDA in 2022 highlights ongoing advancements in the field.

The atherectomy devices market is set to grow substantially due to increasing cardiovascular disease prevalence, technological innovations, and strategic industry developments, despite facing challenges related to costs and regulatory hurdles.

Key Takeaways

• Atherectomy Devices Market sales are projected to surpass USD 2.5 billion by 2032.
• In 2022, the Atherectomy Devices Market was valued at USD 1.2 billion.
• The market is expected to register a CAGR of 8% from 2023 to 2032.
• In 2022, the directional atherectomy segment led the market in revenue.
• Peripheral vascular applications accounted for 45% of the atherectomy devices market share in 2022.
• North America held the highest revenue share in the market at 36% in 2022.
• The APAC region is expected to exhibit the highest growth rate among all regions.
• The American Heart Association reported that cardiovascular disease caused 18.6 million deaths globally in 2019.
• Globally, over 200 million people are estimated to suffer from peripheral artery disease (PAD).
• A study by the AHA found atherectomy devices successful in 94.7% of patients.
• The rate of restenosis after atherectomy procedures was reported to be 37.7%.

Get Sample PDF Report: https://market.us/report/atherectomy-devices-market/request-sample/

Atherectomy Devices Market Key Segments

Based on Product

• Directional Atherectomy Devices
• Rotational Atherectomy Devices
• Orbital Atherectomy Devices
• Laser Atherectomy Devices
• Photo-Ablative Atherectomy Devices
• Support Devices
• Others

Based on Application

• Peripheral Vascular Applications
• Cardiovascular Applications
• Neurovascular Applications

Based on End-User

• Hospitals & Surgical centres
• Ambulatory Care Centres
• Research Laboratories
• Academic Institutes

Key Regions

• North America (The US, Canada, Mexico)
• Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
• Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
• APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
• Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
• Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=101181

Key Players Analysis

Abbott Laboratories is a prominent player in the atherectomy devices market, known for its innovation and strategic acquisitions. In February 2023, Abbott acquired Cardiovascular Systems Inc., enhancing its portfolio with advanced atherectomy systems designed for both coronary and peripheral artery diseases. This acquisition positions Abbott to offer comprehensive vascular treatment solutions, leveraging technologies that improve patient outcomes and expand their market reach​.

Boston Scientific Corporation is a key competitor in the atherectomy devices sector, offering a range of products that cater to diverse cardiovascular and peripheral vascular applications. Their portfolio includes innovative technologies that enhance procedural efficiency and patient safety. Boston Scientific continuously invests in research and development, focusing on improving device performance and expanding their application range to maintain a competitive edge in the market.

Medtronic is a leader in medical technology, with a strong presence in the atherectomy devices market. The company’s products are known for their reliability and effectiveness in treating peripheral and coronary artery diseases. Medtronic’s continuous product innovation and strategic partnerships have enabled it to maintain a robust market position. The company’s focus on developing minimally invasive solutions has driven its growth in this sector​​.

BD Interventional, a segment of Becton, Dickinson and Company, offers the Rotarex Atherectomy System, which has received FDA clearance for expanded indications. BD’s products are designed to address complex vascular conditions, providing physicians with effective tools for removing arterial blockages. Their emphasis on product development and regulatory approvals has strengthened their position in the atherectomy devices market​.

Koninklijke Philips N.V. is recognized for its advanced atherectomy devices, including the Turbo-Elite Laser Atherectomy Catheter and the IntraSight Mobile system. These devices leverage cutting-edge laser technology to treat various vascular conditions effectively. Philips continues to innovate and expand its product offerings, focusing on improving clinical outcomes and patient safety. Their strategic initiatives and technological advancements have solidified their presence in the global market.

Atherectomy Devices Market Key Players:

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic
• Becton, Dickinson, and Company (BD Interventional)
• Koninklijke Philips N.V.
• Avinger Inc.
• Rex Medical
• AngioDynamics
• Cardiovascular Systems Inc.
• Bard Peripheral Vascular Inc.
• Spectranetics St.
• Jude Medical Inc.
• Straub Medical AG
• Terumo IS
• Volcano Corporation
• Others Key Players

Atherectomy Devices Market Report Scope >> Market Value (2022): USD 1.2 Billion || Forecast Revenue (2032): USD 2.5 Billion || CAGR (2023-2032): 8% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.

Inquire More about report: https://market.us/report/atherectomy-devices-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.

Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/

View More Trending Reports

Wearable Injectors Market Projected Surge To USD 20.9 Billion By 2033, With A Steady 12.4% CAGR

Medical Spa Market Projected To Reach USD 50.9 Billion With 13.2% CAGR By 2033

CAR-T Cell Therapies Market Hit USD 10.2 Billion By 2033

Condom Market Will Increase USD 17.9 Billion By 2032

Digital Therapeutics Market Size to Attain USD 62.4 Billion by 2032